Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Vice President – DM1 Commercial Asset Lead

Product MarketingConfirmed live in the last 24 hours

Full-timeWaltham, MA, USA$272k - $340k

About the Job

Requirements

A bachelor's degree in a relevant scientific, medical, or business discipline is required.
A minimum of 20 years of experience in the biopharmaceutical industry is required.
At least 15 years of commercialization and cross-functional leadership experience is required.
Extensive experience leading global product launches, including at least three launches, is required.
A proven track record of delivering business objectives in fast-paced, high-stakes environments is required.
Experience steering assets from late-stage development through approval and launch is required.
Experience influencing global and U.S. market access and reimbursement readiness is required.
Demonstrated success developing global commercialization strategies is required.
Experience collaborating across clinical, medical, regulatory, supply, and commercial functions is required.
The ability to synthesize complex data to guide strategy is required.
Strong cross-functional leadership and stakeholder influence are required.
The ability to inspire and mobilize high-performing teams is required.
Exceptional communication and stakeholder engagement skills are required.
The ability to build strong external relationships with key opinion leaders, advocacy groups, payers, and regulators is required.
The ability to lead through ambiguity and change is required.
High integrity and a strong patient-centric mindset are required.
A strong sense of urgency and the ability to prioritize effectively are required.

Responsibilities

Define the global asset commercialization strategy and plan to achieve milestones and timelines for successful launches.
Shape competitive positioning, differentiation strategy, and the overall value proposition.
Provide commercialization input into program strategy, including label and access considerations.
Establish strategic imperatives, critical success factors, and execution priorities.
Lead global launch planning and readiness across key markets, starting with the United States.
Partner with cross-functional teams, including medical, regulatory, supply, marketing, digital, and data, to prepare for launch execution.
Collaborate with affiliate teams and external partners to support reimbursement and access readiness.
Drive continuous improvement and learning across markets.
Serve as a key member of the Program Team and lead the DM1 Commercial Sub-Team.
Ensure alignment across commercialization pillars, including product profile, access, and launch planning.
Facilitate cross-functional decision-making and drive timely outcomes.
Build partnerships across functions and maintain clear communication with leadership.
Build a credible and visible presence within the DM1 community, including key opinion leaders, patient advocacy groups, and care teams.
Maintain awareness of the competitive landscape and evolving market dynamics.
Support preparation and presentation of commercialization materials for senior leadership and Board discussions.
Participate in business development activities, including opportunity evaluation and due diligence, as needed.

Desired Qualifications

An advanced degree is strongly preferred.
Rare disease experience is strongly preferred.
Neuromuscular experience is highly advantageous.

Company Overview:

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Role Summary:

The VP, DM1 Commercial Asset Lead (CAL) is a passionate driver of the value of Dyne’s DM1 commercial asset with a global perspective, bringing adaptable leadership to develop and implement commercialization strategies that maximize reach and value creation within the neuromuscular portfolio.

This mandate includes market analysis, competitive positioning, launch readiness and execution, and input into lifecycle management to support long-term success in bringing the asset to patients globally. The CAL is a highly visible leadership role and, as a key member of the Program Team, works cross-functionally to influence and help shape Program strategy.

The CAL leads the definition of commercialization strategy, strategic imperatives, critical success factors, executional priorities, and global launch planning in close partnership with affiliate launch teams. This role balances a forward-looking orientation toward broad global access for patients with a pragmatic approach to planning, risk mitigation, and execution. The CAL collaborates with Program Team members, functional leads, and affiliate teams to achieve a differentiated product profile, competitive label, broad reimbursement, and successful global launches, starting with the U.S.

As a member of the Program Team, the CAL is responsible for advancing commercialization readiness and works in strong partnership with the Program Lead, Head of Commercialization, functional leaders, and affiliate launch teams.

This role is based onsite in Waltham, MA.

Primary Responsibilities Include:

Global Commercial Strategy & Asset Leadership

Define global asset commercialization strategy and plan to achieve milestones and timelines for successful launches
Shape competitive positioning, differentiation strategy, and overall value proposition
Provide commercialization input into program strategy, including label and access considerations
Establish strategic imperatives, critical success factors, and execution priorities

Launch Readiness & Market Planning

Lead global launch planning and readiness across key markets, starting with the U.S.
Partner with cross-functional teams (medical, regulatory, supply, marketing, digital, data) to prepare for launch execution
Collaborate with affiliate teams and external partners to support reimbursement and access readiness
Drive continuous improvement and learning across markets

Cross-Functional Leadership & Program Integration

Serve as a key member of the Program Team and lead the DM1 Commercial Sub-Team
Ensure alignment across commercialization pillars (product profile, access, launch planning)
Facilitate cross-functional decision-making and drive timely outcomes
Build strong partnerships across functions and maintain clear communication with leadership

External Engagement & Stakeholder Management

Build a credible and visible presence within the DM1 community, including KOLs, patient advocacy groups, and care teams
Maintain awareness of competitive landscape and evolving market dynamics
Support preparation and presentation of commercialization materials for senior leadership and Board discussions
Participate in business development activities, including opportunity evaluation and due diligence, as needed

Education and Skills Requirements:

Bachelor’s degree in a relevant scientific, medical, or business discipline required; advanced degree strongly preferred
Minimum of 20 years of experience in the biopharmaceutical industry
15+ years of commercialization and cross-functional leadership experience
Extensive experience leading global product launches, including a minimum of 3 launches
Rare disease experience strongly preferred; neuromuscular experience highly advantageous
Proven track record of delivering on business objectives in fast-paced, high-stakes environments
Proven ability to steer assets from late-stage development through approval and launch
Experience influencing global and U.S. market access and reimbursement readiness
Demonstrated success developing global commercialization strategies
Experience collaborating across clinical, medical, regulatory, supply, and commercial functions
Ability to synthesize complex data to guide strategy
Strong cross-functional leadership and stakeholder influence
Proven ability to inspire and mobilize high-performing teams
Exceptional communication and stakeholder engagement skills
Ability to build strong external relationships (KOLs, advocacy, payers, regulators)
Comfortable leading through ambiguity and change
High integrity and strong patient-centric mindset
Strong sense of urgency and ability to prioritize effectively

#LI-Onsite

MA Pay Range

$272,000—$340,000 USD

The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.

The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.

Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

MA Pay Range 272000 - 340000 USD

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size: 201-500
Company stage: IPO
Headquarters: Waltham, MA
Founded: 2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs